MS-N321 · Mindfulness · Anxiety and depression · Cervical cancer or HSIL · Human evidence · Appraised 13 November 2026
Can a six-week online mindfulness program reduce anxiety and depressive symptoms in people with cervical cancer or high-grade squamous intraepithelial lesions?
Evidence at a glance
- Evidence label: Single-center randomized trial; positive short-term symptom findings
- Benefit: Depression and anxiety scales favored mindfulness over general mental-health education after six weeks.
- Certainty: Low to moderate for short-term self-reported psychological symptoms; uncertain for durability and cancer-specific subgroups.
- Risk: Adverse-event reporting was not verified in the accessible abstract; online mindfulness can surface distress and is not a substitute for urgent mental-health care.
What was studied
A single-center trial randomized 151 participants with cervical cancer or HSIL to a six-week online mindfulness intervention or general mental-health education. Primary outcomes were validated depression and anxiety scales; frontal EEG measures were exploratory.
What the evidence found
One hundred forty-nine participants completed the study. After false-discovery-rate correction, depression and anxiety scores were lower in the intervention group (t=12.238 and 11.150; both q<0.001), with higher resilience, mindfulness and perceived support. EEG differences were exploratory and do not demonstrate clinical benefit on their own.
How to interpret it
The report pooled invasive cancer and a precancerous lesion, so applicability to a particular stage or treatment is uncertain. Absolute scale differences, clinically meaningful response proportions, long-term follow-up, adverse events and subgroup results were not available in the abstract.
These outcomes concern symptoms, distress, sleep or supportive care. They do not establish tumor response, delayed recurrence, progression-free survival or longer overall survival.
Practical safety context
Mindfulness is generally low physical risk, but persistent depression, panic, trauma symptoms, suicidal thoughts or inability to function require professional assessment. The program should complement—not delay—cancer treatment, surveillance or indicated psychotherapy and medication.
Questions for the care team
- Were participants with my diagnosis and treatment represented?
- What symptom change would count as clinically meaningful for me?
- Who monitors worsening anxiety, depression or trauma symptoms during an online program?
Funding and conflicts
The study listed support from the CAMS Innovation Fund, the Non-profit Central Research Institute Fund and the Sanming Project of Medicine in Shenzhen. Conflict details were not fully verified from the abstract.
Sources
Last literature search: 13 November 2026. Record appraisal: 13 November 2026. Only the abstract and bibliographic record were verified; unreported details remain not verified. This page is educational and does not replace individualized medical advice.
